These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer]. Stahl F, Schnorr D, Rohde W, Dörner G. Z Urol Nephrol; 1987 Mar; 80(3):135-8. PubMed ID: 3604472 [Abstract] [Full Text] [Related]
5. Sex hormone binding globulin in carcinoma of the prostate. Houghton AL, Turner R, Cooper EH. Br J Urol; 1977 Jun; 49(3):227-32. PubMed ID: 562212 [Abstract] [Full Text] [Related]
10. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt]. Németh A, Morvay J, Vécsei B. Orv Hetil; 1981 Apr 26; 122(17):1017-20. PubMed ID: 7022313 [No Abstract] [Full Text] [Related]
11. Clinical relevance of plasma testosterone and prolactin changes in advanced cancer of prostate treated with diethylstilbestrol or estramustine phosphate. Morales A, Nickel JC. Urology; 1985 Nov 26; 26(5):477-81. PubMed ID: 3904134 [Abstract] [Full Text] [Related]
18. Hypogonadism in male patients with cancer. Garcia JM, Li H, Mann D, Epner D, Hayes TG, Marcelli M, Cunningham GR. Cancer; 2006 Jun 15; 106(12):2583-91. PubMed ID: 16688773 [Abstract] [Full Text] [Related]